What is Prenatal DHA? Docosahexaenoic acid (DHA) is a long-chain omega-3 fatty acid and the most abundant omega-3 fat in the brain and retina. During pregnancy, DHA is transferred from mother to baby across the placenta, with the greatest accumulation occurring during the third trimester when fetal brain growth is most rapid.

🧠 Baby Brain Development

DHA accounts for approximately 20% of total brain lipid content and 60–80% of brain membrane phospholipids. During the third trimester it accumulates at 50–60 mg per day, supporting neurogenesis, neurite outgrowth, and synaptogenesis. Low DHA levels are associated with impaired dopamine, serotonin, and acetylcholine pathways — fundamental to cognition, mood, and motor function.

👁 Baby Vision

DHA is the dominant fatty acid in the retina’s photoreceptor cells. Clinical trials show that infants of mothers supplemented with 800 mg/day DHA demonstrated more rapid visual learning. Premature infants with higher circulating DHA also show better vision and neurodevelopmental outcomes.

🧬 Nervous System Maturation

DHA is essential for fetal central nervous system maturation, with accretion increasing nearly 30-fold in the first two years of life. Prenatal supplementation has been linked to more mature sleep/wake patterns, improved fetal heart rate variability, and higher autonomic and motor scores. Postnatally, DHA continues through breast milk.

🤰 Preterm Birth Prevention

The SAHMRI ORIP trial (5,517 women) showed that women with low DHA (≤4.1%) supplementing with 900 mg/day had significantly fewer early preterm births (<34 weeks). The Cochrane meta-analysis of 70 trials confirmed a 42% reduction. Importantly, women with adequate levels (>4.9%) should avoid over-supplementation.

Understanding Your Result: A optimal Prenatal DHA level is between 4.9% and 8.0%. Levels below 2.2% are considered low, indicating insufficient omega-3 intake and an increased risk of early preterm birth. Levels between 2.2% and 4.9% are suboptimal and may benefit from dietary changes and targeted supplementation. Levels above 8.0% are elevated, and high-dose supplementation should be discussed with your healthcare provider. Testing is recommended before 20 weeks gestation to allow time for intervention if needed.